Dr. Terrence P. O'Brien, MD

Dr. O'Brien practices at Bascom Palmer Eye Institute in Miami, Florida.

Dr. O'Brien's NPI, 1861417396, was assigned on July 13, 2006. Dr. O'Brien graduated from University Of Michigan Medical School in 1985. Dr. O'Brien holds Florida license ME94070.

Dr. O'Brien's primary practice is Bascom Palmer Eye Institute, at 900 NW 17th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 326-6031.

Dr. O'Brien's primary practice is Bascom Palmer Eye Institute in Miami, Florida. Dr. O'Brien is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. O'Brien to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. O'Brien practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. O'Brien's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. O'Brien is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. O'Brien's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. O'Brien treats.

CMS data shows 1,945 Medicare services from Dr. O'Brien across 17 procedure codes in 2024, for 949 Medicare patients. Medicare paid $190,257 for them.

CMS counts 949 Medicare patients who saw Dr. O'Brien in 2024. The largest group is 75 to 84, with 449 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. O'Brien's median patient age at 74, with 55% women.

In 2024, Dr. O'Brien wrote 1,873 Medicare Part D claims for 516 patients. 49% of them were for generic drugs. CMS names the drug for 1,729 of them, across 26 drugs with 11 or more claims each, at $235,567 in total drug cost. In 2023, CMS named 1,901 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. O'Brien for performance year 2024, reported as part of a group. Dr. O'Brien accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 76 procedures of cataract surgery by Dr. O'Brien, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 123 papers to Dr. O'Brien, published from 2005 to 2021. 2008 was the busiest year, with 5. The most frequent topics are Cornea, Keratomileusis, Laser In Situ and Ophthalmic Solutions. Dr. O'Brien has published most often in J Cataract Refract Surg. Dr. O'Brien's most frequent co-authors are Sonia H. Yoo, MD, William W. Culbertson, MD and Eduardo Alfonso, MD.

CMS Open Payments shows 231 general payments to Dr. O'Brien from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Shire North American Group Inc paid the most, $62,658.

Dmand AI lists 2 awards for Dr. O'Brien, most recently Super Doc in 2014.

Dr. O'Brien graduated from University Of Michigan Medical School in 1985.

Dr. O'Brien is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.